LOXO-435 is a selective small molecule inhibitor of FGFR3. It is active against both wild-type and oncogenically activated FGFR3, including FGFR3 fusion, point mutations, and expected acquired gated site resistance mutations.
For research use only. We do not sell to patients.
Name | LOXO-435 |
---|---|
Iupac Chemical Name | (S)-4-(4-(3-chloro-4-(1-(5-fluoropyridin-2-yl)-2-hydroxyethoxy)pyrazolo[1,5-a]pyridin-6-yl)-5-methyl-1H-1,2,3-triazol-1-yl)piperidine-1-carbonitrile |
Synonyms | LOXO-435 ; LOXO435 ; LOXO 435 |
Molecular Formula | C23H22ClFN8O2 |
Molecular Weight | 496.93 |
Smile | CC1=C(N=NN1C2CCN(CC2)C#N)C3=CN4N=CC(Cl)=C4C(O[C@@H](C5=NC=C(C=C5)F)CO)=C3 |
InChiKey | OYUCEQFRNJABJW-OAQYLSRUSA-N |
InChi | InChI=1S/C23H22ClFN8O2/c1-14-22(29-30-33(14)17-4-6-31(13-26)7-5-17)15-8-20(23-18(24)10-28-32(23)11-15)35-21(12-34)19-3-2-16(25)9-27-19/h2-3,8-11,17,21,34H,4-7,12H2,1H3/t21-/m1/s1 |
CAS Number | 2833703-74-3 |
Related CAS | 2833703-74-3 |
Packaging | Price | Availability | Purity | Shipping Time |
---|---|---|---|---|
Bulk | Enquiry | Enquiry | Enquiry |
Formulation | Solid powder |
---|---|
Purity | ≧98.0% |
Storage | Dry, dark and at 0 - 4℃ for short term (days to weeks) or -20℃ for long term (months to years). |
Solubility | Soluble in DMSO (DMSO : ≥ 100 mg/mL) |
Handling | Refer to MSDS |
Shipping Condition | Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs. |
HS Code | 2934200090 |
Targets | |
---|---|
Mechanism | |
Cell study | |
Animal study | |
Clinical study |